• About Us
    • About Us
    • Our Team
    • Worldwide Activity
  • Corporate Finance
    • Corporate Finance
    • Life Sciences
    • High Tech
    • Mobility & AI
    • Foodtech & Agritech
    • Secondary Markets
    • Real Estate
  • Transactions
  • Family Office
  • Social Responsibility
  • Private Equity Fund
  • Conferences
  • News
  • Contact Us
Eloxx Pharmaceuticals Announces FDA Grant of Orphan-Drug Designation for Investigational Drug ELX-02 for Treatment of Cystinosis

Eloxx Pharmaceuticals Announces FDA Grant of Orphan-Drug Designation for Investigational Drug ELX-02 for Treatment of Cystinosis

by Cukierman & Co | Apr 30, 2018 | News & Updates, Recent Updates

Eloxx Pharmaceuticals Announces FDA Grant of Orphan-Drug Designation for Investigational Drug ELX-02 for Treatment of Cystinosis

Israeli Policymakers Divided Over Response to U.S. Tax Policy

by Cukierman & Co | Apr 30, 2018 | News & Updates, Recent Updates

In the past five years, Chinese investors have accounted for some $15 billion of the approximately $25 billion invested in Israeli technology, said Edouard Cukierman, chairman of Cukierman & Co. Investment House Ltd. and managing partner of Catalyst Investments in...
Eloxx Pharmaceuticals Announces FDA Grant of Orphan-Drug Designation for Investigational Drug ELX-02 for Treatment of Cystinosis

以色列半导体行业 – Israel Semiconductor Industry

by Cukierman & Co | Apr 29, 2018 | News & Updates, Recent Updates

צפויה להתמזג עם עמיר שיווק BOL :קנאביס בבתי מרקחת

צפויה להתמזג עם עמיר שיווק BOL :קנאביס בבתי מרקחת

by Cukierman & Co | Apr 12, 2018 | Globes, News & Updates, Recent Updates

Eloxx Pharmaceuticals Announces FDA Grant of Orphan-Drug Designation for Investigational Drug ELX-02 for Treatment of Cystinosis

Tufin Announces Security Automation for Containers and Microservices

by Cukierman & Co | Apr 12, 2018 | News & Updates, Recent Updates, Tufin

Search

  • Blog – Foodtech and Agritech
  • Blog – Life Science
  • Blog – Technology, Media and Telecom
  • Capital markets
  • Corporate Finance
  • Featured News
  • Forbes
  • Globes
  • GoforIsrael
  • haaretz
  • i24news
  • Israel 21
  • Jewish Business
  • LeMag
  • merger market
  • News & Updates
  • Non classé
  • Podcast
  • Private equity
  • Recent Updates
  • Services
  • Team
  • Time of Israel
  • Tufin
  • Ynet
  • The missing piece of Israel’s venture capital story
  • Analysis | It’s Not the Rifle That Matters, but the System: How the Battlefield of the 21st Century Is Changing
  • What makes a DefenseTech company a good investment?
  • What makes a DefenseTech company a good investment?
  • Michael Cukierman has been appointed Partner and Head of the Defense Division at Cukierman Investment House

Leading Israeli Corporate Finance Investment House

Home
About Us
Corporate Finance
Transactions
Family Office
Social Responsibility
Private Equity Fund
GoForIsrael Conferences
News
Contact Us

Corporate Finance

Corporate Finance

 

Life Sciences

Life Sciences

 

High Tech

High Tech
Mobility & AI
Cyber Security
IT Services
Telecom

Foodtech & Agritech

Foodtech & Agritech

 

Real Estate

Real Estate
  • Follow
  • Follow

© 2025 Cukierman & Co. Investment House Ltd. All rights reserved.

Powered by